Visalytics
Visalytics
approved EB-2 (NIW)

Visiting Postdoctoral Fellow

Cancer Biology · Taiwan · 2025-06-02

Processing Time
26 days
Decision Date
2025-06-02
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses urgent challenges in modern oncology and drug resistance, which is of significant value to U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 379 citations and 10 peer-reviewed articles demonstrate a track record of success and influence in cancer biology.

3 Balance of Interests Met

The petitioner’s contributions to precision medicine and therapeutic innovation justify a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 10 peer-reviewed journal articles and 4 conference abstracts which garnered 379 citations, demonstrating widespread academic influence. The case successfully met all three Dhanasar prongs without the need for recommendation letters by highlighting unsolicited speaking invitations and tangible outcomes in precision medicine. The processing was expedited via premium processing, resulting in approval in 26 days.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Missouri 49 days 2025-04-01
The petitioner proposes to identify novel therapeutic targets to improve personalized medicine and enhance treatment outcomes for cancer patients. Her work focuses on addressing drug resistance in oncology by integrating synthetic biology, protein engineering, and tumor signaling analysis to develop optimized drug delivery methods.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
69 days 2026-01-26
The petitioner proposes to continue research on elucidating molecular mechanisms and identifying novel therapeutics for rare and advanced metastatic cancers. The work involves using cell-based assays, advanced biotechnological approaches, and computer-aided drug design to advance personalized medicine and improve patient survival outcomes.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 380 days 2025-04-30
The petitioner proposes to continue research in cancer biology, specifically focusing on the development of gene therapy and immunotherapy. This work involves creating novel non-invasive monitoring methods to improve treatment effectiveness while reducing patient discomfort. The endeavor aims to advance precise cancer treatments and improve public health outcomes in the United States.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 26 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist